Back to Trades
Megiddo Dalia
Chief Development OfficerDirectorCIK 0001599618
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Megiddo Dalia, Chief Development Officer, Director, accounts for 1 disclosed filing worth $0, all concentrated in Nasus Pharma Ltd (NSRX), active 2026. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Mar 27 | NSRX Nasus Pharma Ltd | Megiddo Dalia | Chief Development Officer, Director | Other | $0 |
1 filing